Search research articles
Contact Us
Filters
Showing results (1-10 of 411) with videos related to
Page
of 42
Sort By:
The Lancet. Oncology
|
May 23, 2025
Demystifying the WHO Model Lists of Essential Medicines for cancer care
Dario Trapani, Elisabeth G E de Vries
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2008
Exploiting the apoptotic route for cancer treatment: a single hit will rarely result in a home run
Elisabeth G E de Vries, Steven de Jong
JAMA Oncology
|
August 22, 2018
Improving on Tail-of-the-Curve Evaluation With the American Society of Clinical Oncology Value Framework
Nathan I Cherny, Elisabeth G E de Vries,
The Lancet. Oncology
|
May 4, 2020
The global imperative to make cancer medications affordable
Nathan I Cherny, Elisabeth G E de Vries
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
September 10, 2003
Intraperitoneal chemotherapy for ovarian cancer: a question of feasibility?
Pax H B Willemse, Elisabeth G E de Vries
JAMA Oncology
|
October 18, 2019
Correcting the Conclusion in a Study of Frameworks for Measurement of Absolute or Relative Clinical Survival Benefit
Urania Dafni, Nathan I Cherny, Elisabeth G E de Vries
The Lancet. Oncology
|
April 4, 2019
ESMO-MCBS: setting the record straight
Nathan I Cherny, Josep Tabernero, Elisabeth G E de Vries
The Journal of Pathology
|
January 17, 2002
Fas receptor-mediated apoptosis: a clinical application?
Tineke Timmer, Elisabeth G E de Vries, Steven de Jong
JAMA Oncology
|
February 25, 2021
Current Treatment Strategies and Future Directions for Extrapulmonary Neuroendocrine Carcinomas: A Review
Johannes Stelwagen, Elisabeth G E de Vries, Annemiek M E Walenkamp
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 30, 2016
Emerging Opportunities for c-MET Visualization in the Clinic
Martin Pool, Gooitzen M van Dam, Elisabeth G E de Vries
Page
of 42
Search research articles
Search
Showing results (1-10 of 411) with videos related to
Sort By:
Page
of 42
The Lancet. Oncology
|
May 23, 2025
Demystifying the WHO Model Lists of Essential Medicines for cancer care
Dario Trapani, Elisabeth G E de Vries
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2008
Exploiting the apoptotic route for cancer treatment: a single hit will rarely result in a home run
Elisabeth G E de Vries, Steven de Jong
JAMA Oncology
|
August 22, 2018
Improving on Tail-of-the-Curve Evaluation With the American Society of Clinical Oncology Value Framework
Nathan I Cherny, Elisabeth G E de Vries,
The Lancet. Oncology
|
May 4, 2020
The global imperative to make cancer medications affordable
Nathan I Cherny, Elisabeth G E de Vries
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
September 10, 2003
Intraperitoneal chemotherapy for ovarian cancer: a question of feasibility?
Pax H B Willemse, Elisabeth G E de Vries
JAMA Oncology
|
October 18, 2019
Correcting the Conclusion in a Study of Frameworks for Measurement of Absolute or Relative Clinical Survival Benefit
Urania Dafni, Nathan I Cherny, Elisabeth G E de Vries
The Lancet. Oncology
|
April 4, 2019
ESMO-MCBS: setting the record straight
Nathan I Cherny, Josep Tabernero, Elisabeth G E de Vries
The Journal of Pathology
|
January 17, 2002
Fas receptor-mediated apoptosis: a clinical application?
Tineke Timmer, Elisabeth G E de Vries, Steven de Jong
JAMA Oncology
|
February 25, 2021
Current Treatment Strategies and Future Directions for Extrapulmonary Neuroendocrine Carcinomas: A Review
Johannes Stelwagen, Elisabeth G E de Vries, Annemiek M E Walenkamp
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 30, 2016
Emerging Opportunities for c-MET Visualization in the Clinic
Martin Pool, Gooitzen M van Dam, Elisabeth G E de Vries
Page
of 42